Pancragen for Pancreatic Health & Metabolic Support — Bioregulators
Khavinson bioregulator peptide for pancreatic tissue regeneration and glucose metabolism optimization.
Overview
Pancragen is a Khavinson bioregulator targeting pancreatic tissues for metabolic health optimization and glucose regulation support. Through DNA-level gene regulation in pancreatic cells, Pancragen promotes insulin-producing beta cell health, supports digestive enzyme production, and optimizes pancreatic function. It's particularly valuable for metabolic syndrome, pre-diabetes support, pancreatic aging, and digestive health.
Indications
- Metabolic syndrome and pre-diabetes support
- Pancreatic tissue repair and regeneration
- Glucose metabolism optimization
- Digestive enzyme production support
- Pancreatic function in aging
- Post-pancreatitis recovery support
- Type 2 diabetes supportive therapy (not replacement)
Mechanism of Action
Age-related beta cell decline, metabolic syndrome, or pancreatic tissue damage
Dosing
| Compound | Dose | Frequency | Notes |
|---|---|---|---|
| Pancragen | 20 mg | Once daily with meals | Metabolic health maintenance and pancreatic support |
| Pancragen | 20 mg | Twice daily with meals for first 2 months, then once daily | For metabolic syndrome or pancreatic dysfunction |
Safety & Contraindications
- Emerging evidence - Russian endocrinology studies
- Not a replacement for diabetes medications
- Monitor blood glucose and HbA1c during use
- Consult endocrinologist with diabetes or pancreatic disease
- No pancreatic toxicity reported in clinical trials
- Safe for long-term metabolic support based on available data